NCT04302545

Brief Summary

Part1:The healthy pregnant women with previous operative deliveries admitted for elective C-section will be counselled and conditioned informed consent will be taken to be included in either study group if dense pelvic adhesions will be found during their operation. Adhesiolysis will be performed using bladder retro-fill with 300cc saline in the cystoinflation group, and without retro-fill in control.Both groups will be observed for bladder injury rate,bloodloss,operativetime,urinary tract infection,micturition problems and fistula formation. Part2\&3:Summary of Part 2 and 3 will be provided after publication

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
564

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2017

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

March 6, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 10, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2021

Completed
5 months until next milestone

Results Posted

Study results publicly available

September 28, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
Last Updated

September 4, 2024

Status Verified

August 1, 2024

Enrollment Period

3.7 years

First QC Date

March 6, 2020

Results QC Date

February 17, 2021

Last Update Submit

August 8, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Bladder Injury Rate

    The bladder injury will be detected by direct visualization in the cesarean section before delivery of the baby during adhesiolysis of dense adhesions of the lower uterine segment, which cover and obscure the bladder. The bladder injury outcome will be measured as the number(percentage) of subjects with injury.

    From the confirmation of adhesions to adhesiolysis and separation of bladder flap from uterus, before delivery of the baby during cesarean section.This time frame can range between 10-20 minutes.

  • Blood Loss

    Amount of blood loss during C-section will be increase in weight of sponges used during operation, taking 1gram equal to 1cc.

    From the confirmation of adhesions to adhesiolysis and separation of bladder flap from uterus, before delivery of the baby during cesarean section.This time frame can range between 10-20 minutes.

  • Operative Time

    Time from incision till closure of skin

    During Caesarean section

Secondary Outcomes (9)

  • White Blood Cells Count Per High Power Feild

    3rd postoperative day

  • Urine Culture Report for Micro-organisms

    2nd postoperative day

  • Fever

    upto 3months

  • Postmicturition Bladder Volume After C-section

    upto 3months

  • Composite Micturition Problems During Hospital Stay

    Complaint recorded during hospital stay (range between 4-21 days)

  • +4 more secondary outcomes

Study Arms (2)

Cystoinflation group

EXPERIMENTAL

Bladder will be recognized by observing its gradual distension during bladder retro-fill with 300cc saline to perform adhesiolysis.

Procedure: Cystoinflation

Control group

NO INTERVENTION

Pelvic adhesiolysis will be performed without bladder retrofill.

Interventions

Bladder retrofill with 300cc saline to distend the bladder to recognize bladder outline

Also known as: Bladder retrofill
Cystoinflation group

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspart1:Pregnant women Part2:Assigned to abdominal hysterectomy Part3:pregnant women with placenta accreta spectrum
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy pregnant women of any age
  • Two or more previous C-sections
  • Gestational age between 38-40 weeks (confirmed by dating scan)
  • Dense Adhesions of Tulandi scores four or more.
  • women who give informed consent to participate in the study

You may not qualify if:

  • :• Patients with medical disorders
  • Bladder injury before group assignment
  • Placenta previa
  • Subjects experiencing micturition problems (dysuria, frequency, urgency, urinary retention, incontinence) before the study.
  • Eligibility criteria of part 2\&3 will be provided after publication -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lady Willingdon Hospital

Lahore, Punjab Province, 042, Pakistan

Location

Related Publications (5)

  • O'Hanlan KA. Cystosufflation to prevent bladder injury. J Minim Invasive Gynecol. 2009 Mar-Apr;16(2):195-7. doi: 10.1016/j.jmig.2008.11.011. Epub 2009 Jan 9.

  • Pandey D, Mehta S, Grover A, Goel N. Indwelling Catheterization in Caesarean Section: Time To Retire It! J Clin Diagn Res. 2015 Sep;9(9):QC01-4. doi: 10.7860/JCDR/2015/13495.6415. Epub 2015 Sep 1.

  • Abdel-Aleem H, Aboelnasr MF, Jayousi TM, Habib FA. Indwelling bladder catheterisation as part of intraoperative and postoperative care for caesarean section. Cochrane Database Syst Rev. 2014 Apr 11;2014(4):CD010322. doi: 10.1002/14651858.CD010322.pub2.

  • Joelsson-Alm E, Nyman CR, Svensen C, Ulfvarson J. Micturition problems after bladder distension during hospitalization in Sweden: "I'm not ill, just damaged for the rest of my life". Nurs Res. 2014 Nov-Dec;63(6):418-25. doi: 10.1097/NNR.0000000000000057.

  • Saaqib S, Naheed M, Iqbal A, Rehman RMAU, Khalid M. Evaluating a novel approach to placenta accreta spectrum management: the modified Triple-P technique with cystoinflation (a randomized controlled trial). Sci Rep. 2025 Jul 16;15(1):25870. doi: 10.1038/s41598-025-07582-6.

Results Point of Contact

Title
Shazia Saaqib
Organization
King Edward Medical University, Lahore, Pakistan

Study Officials

  • Munazza Naheed, MBBS

    King Edward Medical University

    STUDY DIRECTOR
  • Tayyaba Saeed, MBBS

    King Edward Medical University

    STUDY DIRECTOR
  • Mohammad Khalid, MBBS, MHM

    Institute of Public Health, Pakistan

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participants and outcome assessors are kept blind by just entering the random number assigned to the subject on the papers and notes are written without details of adhesiolysis. The completed outcome performas are sent to the assessors with the only random number entered and without the assigned group. The random number file is opened only after receiving results from the statistician. The care providers in theatre and principle surgeon cannot be blinded in this study.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Subjects will be assigned into cystoinflation group and control group after parallel assignment. In the cystoinflation group, the intervention will be retro-fill of the bladder with 300cc saline and clamping the drainage port of the catheter till the completion of adhesiolysis. In contrast, the urinary catheter of control group patients will be put on free drainage.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor Gynecology and Obstetrics

Study Record Dates

First Submitted

March 6, 2020

First Posted

March 10, 2020

Study Start

August 1, 2017

Primary Completion

April 30, 2021

Study Completion

April 30, 2022

Last Updated

September 4, 2024

Results First Posted

September 28, 2021

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

No: There is no plan to make individual participant data available. The data will be made available to individual researchers on request after publication.

Locations